Blackstone’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.8M Buy
+418,109
New +$9.39M 0.04% 83
2025
Q3
– Sell
-100,000
Closed -$2.67M – 288
2025
Q2
$2.67M Buy
+100,000
New +$2.7M 0.01% 108

Other funds holding CAI

Blackstone's CAI Position: Q3 2026 in Review

Blackstone opened a new position in Caris Life Sciences (CAI) in Q3 2026: 418,109 shares worth $12.8M. The stake represents 0.04% of the portfolio and ranks #83 among its holdings. This is a return to the name: Blackstone previously reported a position in CAI as recently as Q2 2025.

Blackstone first reported a position in CAI in Q2 2025 and has held it in 2 quarters since. 330 funds tracked by Wall St. Rank hold CAI as of Q3 2026.

  • Blackstone held 418,109 shares of Caris Life Sciences worth $12.8M as of Q3 2026.
  • Caris Life Sciences was a new Blackstone position in Q3 2026.
  • Caris Life Sciences made up 0.04% of Blackstone's portfolio in Q3 2026, its #83 holding.
  • Blackstone first reported a position in Caris Life Sciences in Q2 2025 and has held it in 2 quarters since.
  • 330 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.

Based on Blackstone's 13F filing for Q3 2026, filed 16 Nov 2026.